Integra Lifesciences (IART)
$24.54 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Integra Lifesciences, AI stock picks, stock alerts and much more.
IART AI Stock Analysis
AI stock analysis for IART is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Integra Lifesciences (IART) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
IART Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Integra Lifesciences (IART), currently trading at $24.54, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About IART
-
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.
-
Symbol
IART
-
Market
NASDAQ
-
Industry
Medical - Devices
-
Market Cap
1.9B
Similar Stocks
 |
Align Technology ALGN |
$229.7 0.8% |
6 |
 |
iRhythm Technologies IRTC |
$89.02 8% |
5 |
 |
Silk Road Medical SILK |
$27.49 0% |
6 |
 |
Cutera CUTR |
$0.457 16.6% |
3 |
 |
Dexcom DXCM |
$78.1 0.2% |
6 |
IART Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
IART Financials
IART Key Metrics
-
Total Revenue
$380.8M
-
Net Income
-$10.7M
-
Earnings per Share
-$0.14
-
Free cash flow
-$7.2M
-
EBITDA
-$8.2M
-
EBITDA Ratio
-0.0214004
-
Total Assets
$4.1B
IART 2-year Revenue & Income
IART 2-year Free Cash Flow
IART Technicals
IART SMA
IART RSI
FAQ
What's the current price of Integra Lifesciences (IART) Stock?
The price of an Integra Lifesciences (IART) share is $24.54.
What's the market cap of Integra Lifesciences?
The current market cap of Integra Lifesciences is 1.9B.
Should I buy or sell IART?
Integra Lifesciences shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Integra Lifesciences is better viewed as a hold or accumulate position while waiting for further developments.
Is Integra Lifesciences a good investment?
The current analysis of Integra Lifesciences' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Integra Lifesciences' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Integra Lifesciences (IART) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Integra Lifesciences stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Integra Lifesciences (IART) that investors often compare it to?
Integra Lifesciences (IART) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Silk Road Medical, Cutera and Dexcom.
What is the forecast for Integra Lifesciences' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Integra Lifesciences' stock price to be around $23.77 in 2025. Starting from the current price of $24.54, this represents a 3.1% change in price, indicating a neutral outlook for the stock.
How to buy Integra Lifesciences (IART) Stock?
Integra Lifesciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Integra Lifesciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.